Publication

Byline

Location

US Patent Issued to Blueprint Medicines on Oct. 27 for "Treatment of eosinophilic disorders with avapritinib" (Massachusetts Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,409, issued on Oct. 27, was assigned to Blueprint Medicines Corp. (Cambridge, Mass.). "Treatment of eosinophilic disorders with avapritinib... और पढ़ें


US Patent Issued to NATCO PHARMA on Oct. 27 for "EGFR inhibitor for the treatment of head and neck cancer" (Indian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,410, issued on Oct. 27, was assigned to NATCO PHARMA Ltd. (Hyderabad, India). "EGFR inhibitor for the treatment of head and neck cancer" wa... और पढ़ें


US Patent Issued to Biossil, Board of Regents of the University of Texas System on Oct. 27 for "Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent" (Missouri, Texas, Iowa Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,411, issued on Oct. 27, was assigned to Biossil Inc. (Toronto) and Board of Regents of the University of Texas System (Austin, Texas). "Com... और पढ़ें


US Patent Issued to Immedica Pharma US on Oct. 27 for "Ganaxolone for use in treatment of super refractory status epilepticus" (Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,412, issued on Oct. 27, was assigned to Immedica Pharma US Inc. (Radnor, Pa.). "Ganaxolone for use in treatment of super refractory status ... और पढ़ें


US Patent Issued to CROSSJECT on Oct. 27 for "Pharmaceutical hydrocortisone solution for injection device" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,413, issued on Oct. 27, was assigned to CROSSJECT (Dijon, France). "Pharmaceutical hydrocortisone solution for injection device" was invent... और पढ़ें


US Patent Issued to National Chung Hsing University on Oct. 27 for "Method for treating cancer using human mitochondrial malic enzyme 2 inhibitor" (Taiwanese Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,415, issued on Oct. 27, was assigned to National Chung Hsing University (Taichung City, Taiwan). "Method for treating cancer using human mi... और पढ़ें


US Patent Issued to Coolhouse Resourcing on Oct. 27 for "Composition, article and method for affecting a mammal" (Colorado, Minnesota Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,416, issued on Oct. 27, was assigned to Coolhouse Resourcing LLC (Minneapolis). "Composition, article and method for affecting a mammal" wa... और पढ़ें


US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM on Oct. 27 for "Dilutable formulations of cannabinoids and processes for their preparation" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,417, issued on Oct. 27, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Jerusalem). "Diluta... और पढ़ें


US Patent Issued to LUNELLA BIOTECH on Oct. 27 for "Alkyl-TPP compounds for mitochondria targeting and anti-cancer treatments" (Canadian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,418, issued on Oct. 27, was assigned to LUNELLA BIOTECH INC. (Ontario, Canada). "Alkyl-TPP compounds for mitochondria targeting and anti-ca... और पढ़ें


US Patent Issued to PLEX PHARMACEUTICALS on Oct. 27 for "Pharmacological agents for treating conditions of the eye" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,419, issued on Oct. 27, was assigned to PLEX PHARMACEUTICALS INC. (San Diego). "Pharmacological agents for treating conditions of the eye" ... और पढ़ें